kora - kooperative gesundheitsforschung in der region augsburg

Font size »A . A+ . A++ .

Study types

  • cross-sectional studies (representative surveys) more ...
  • case control study more ...
    • identifying cases from surveys (diabetes, allergies, fractures -> also, e.g., cost of illness studies)
    • identification of population-based controls
  • family studies: identification of cases from survey and inclusion of their families (myocardial infarction, diabetes)
  • cohort studies. more ...



Cross-sectional studies (representative surveys)

population-representative cross-sectional health survey of the resident population aged 25 – 74 with regard to

  • trends and determinants of cardiovascular and metabolic diseases (epidemiology)
  • stratifying risk factors, health care and health according to social status and social relations (social epidemiology)
  • determinants and effects of health care and its utilization (health care research)
  • costs of illness and health care (health economics and health care management)

top

 

Advantages of KORA controls:

  • continuous accumulation of genetic and phenotypic data on the same individuals
  • highly standardized sampling and sample handling
  • focus on a standardized subset of controls for SNP analyses



KORA control subset:

Survey 2000 – sub-sample for genetic analyses
stratification according to age and sex (n = 1,000)
25 - 34 25 - 34 35 - 54 55 - 64 65 - 74
men 100 100 100 100 100
women 100 100 100 100 100
additional inclusion of upper age groups
25 - 34 25 - 34 35 - 54 55 - 64 65 - 74
- - - + 300 + 300
- - - + 300 + 300
altogether approx. 2200 KORA controls

top

 

 Cohort studies:

  • Follow-up of the MONICA/KORA surveys, multi-leveled
    • by means of researching addresses of all participants (for deceased also cause of death)
    • by means of a follow-up postal survey (GEFU1: 1998, GEFU2: 2002, GEFU3: 2008): multiple page questionnaire on chronic diseases
    • in the framework of the follow-up Studies F3 and F4
  • Outcomes:
    • mortality
    • morbidity (in particular myocardial infarct, diabetes)
    • modification in baseline variables (amongst others risk factors)

top